company presentation eigenkapitalforum · 2,000 1,500 1,000 500 0 2008 2009 2010 2011 share buy...

Company PresentationEigenkapitalforum

November 23rd, 2011Frankfurt am Main

2

• UMS at a Glance

• New Markets and Treatment Forms

• Financials: Actual & Outlook

• The UMS Share

Agenda

3

UMS at a Glance

UMS provides mobile „roll-in, roll-out“ health careservices on a regularly scheduled basis

• Founded 1988 in Quickborn near Hamburg

• UMS today is the leader in the United States for a variety of transportable medical services

• UMS offers advanced mobile medical solutions to hospitals, ambulatory surgery centers and physicians' offices

• Serviceprovider across the United States, as well as in Canada and South America

4

UMS at a Glance

Providemobile

Procedures

• UMS targets clinical procedures where patient volumes do not justify the investment in equipment and personnel

• UMS develops (with manufacturers) medical technologies formobile deployment

Achieve High Utilization

• UMS services numerous clinics and physicians with one mobile system on a fee-per-day basis

• UMS drives asset utilization to up to ten times higher than if themedical center purchased the equipment

Create Quality &

Efficiencies

• High utilization of the system clearly reduces the costs oftreatment per patient

• UMS services benefit hospitals, physicians and patients

5

Physicians

FacilityFee

Medical S

ervices Fee

Technician and E

quipment Fee

Physician Fee

Payor

Partnership ASC

Today: Hospitals and ASCs bill and collect from government and commercial payors

Healthcare Facility

Medical

Services Fee

Managem

ent Fee

UMS at a Glance

6

UMS at a Glance

- Service platform in 34 states and four countries

- Around 28,000 lithotripsy procedures (2010)

- Around 13,500 stereotactic breast biopsy treatments (2010)

- Offer most lithotripsy services through limited partnerships with over 500 physicians

- Low direct payor exposure

- Diversified customer bases of around 650 long-term contracts

Overview of Business

7

UMS at a Glance

Segment Overview

Medical Segment (9/2011) 1-9/2011 Revenue by Segment

Total 2011 Revenue: € 38 – 40 million

Urology- Lithotripsy- Laser- Brachytherapy

Breast Care- Stereotactic

Breast Biopsy

Radiology- MRI

56 units

32 units

7 units

Urology 69%

Breast Care 27% Other 4%

New Markets and Treatments

• Q1/2011: Additional Litho Unit established in CON-State Michigan

• H1/2011: New Litho Partnershipformed in Florida, Virginia, Massachusetts

• Q1/2011: Additional MR unitestablished

• Q2-Q3/2011: Evaluation of thePeru market potential

UMS USA

UMS Canada

UMS Chile

UMS Ecuador

2 countries

34 states

UMS continues to expand the existing business segments organically …

New Markets and Treatments

Breast Surgical Services (Dec. 31, 2010)• US-State Texas• 10 contracts

Mobile Biopsy (Apr. 15, 2011)• South-East U.S.• 50 contracts

2 countries

… and through acquisitions

New Markets and Treatment

• May 2011: UMS partners withIceCure to develop mobile deployment of IceCure‘s medicalproduct IceSense3

• IceSense3 is FDA-approved forthe treatment of benign tumors in the breast

• In the US alone, approximately500,000 of these tumors aresurgically removed each year

2 countries

UMS adapts new technologies to its concepts

11

Revenues 29.4 27.3 28.3 1.0 4%

Gross Profit 14.9 13.8 13.5 -0.3 -2%in % 51% 51% 48%

EBIT 9.7 9.0 8.7 -0.3 -4%

EBITDA 12.4 11.5 11.5 - -

EBITDA – MIN 7.3 7.2 6.8 -0.4 -5%

Net Income 7.5 7.0 6.9 -0.1 -1%

EPS in EUR 0.46 0.43 0.36 -0.06 -15%

Financials: Actual & Outlook

Financial Statements 30/09/2011 – Key Indicators

Q1-Q3/10 Q1-Q3/10 Q1-Q3/11 Changein € millions 1

1currency adjusted

1

1

1

1

1

1

1

12

Financials: Actual & Outlook

89

1011121314151617

Q1 Q2 Q3 Q4

20112010

Earnings per share (€): Q3/11 substantially improved over Q2/11

13

Financials: Actual & Outlook

Fiscal year 2011

2011 forecast: EPS appr. € 0.45 – 0.55 (2010: € 0.61)

Development in 2011 has been adversely affected by- Exchange Rate EUR/USD (2010: 1,32/1-9/2011: 1,41) - Mobile Biopsy Integration Costs- Slow utilization ramp up of third MR unit

UMS has adjusted the earning targets for 2011 accordingly

14

Financials: Actual & Outlook

Fiscal year 2012

Looking ahead to 2012, we expect- significant revenue and earnings improvements in our radiology services

business - full integration of Mobile Biopsy- organic growth in Lithotripsy - significant progress in strategic initiatives (e.g. IceCure Cooperation)- clear improvement over fiscal 2011

15

The UMS Share

UMSS-Dax

Share Price influenced by

- Dividend policy- Earnings expectations- Market volatility

Dividend 2010

Profit warning

16

UMS AG expects to maintain its dividend policy for fiscal year 2011

The UMS Share

pre 2009 2009 2010

EPS: €0.48

EPS: €0.61 EPS target 2011:

€0.45 - €0.55

Dividend per share

€0.50

€0.30

17

The UMS Share

Distribution to shareholders(€ thousands)4,000

3,500

3,000

2,500

2,000

1,500

1,000

500

02008 2009 2010 2011

Share buy back

Dividend

18

Annex

19

Number of shares 4,873,284

Segment Prime Standard

ISIN DE0005493654

Reuters UMS.DE

Stock exchange price Nov. 14th, 2011 6.00 Euro

Market capitalization Nov. 14th, 2011 29.2 Mill. Euro

Average daily turnover (LTM) 6,094 shares

The UMS Share

20

Shareholders actual*

The UMS Share

Free Float: 48.5%

CEO: 7.1%

Thomas J.C. Matzen GmbH: 20.9%Union Investment: 4.4%

Supervisory Board: 11.0%

Capiton Value Bet. GmbH: 8.1%

* nach vorliegenden Mitteilungen von Anteilseignern gemäß denVorschriften des deutschen Wertpapierhandelsgesetzes (WpHG)

21

Financial CalendarMarch 2012: Preliminary Results 2011

April 2012: Annual Report 2011

May 15, 2012: Interim Report Q1/2012

May 31, 2012: Annual Shareholders‘ Meeting, Hamburg

August 14, 2012: Interim Report Q2/2012

The UMS Share

22

Executive Board:Jorgen Madsen, CEO

Investor Relations:Wiebke Budwaschfon: +49 40 50 01 77 00fax: + 49 40 50 01 77 77 e-mail: investor@umsag.com Internet: www.umsag.com

edicto GmbHAxel Mühlhaus/Werner Rüppelfon: +49 69 905505 – 52fax: +49 69 905505 – 77e-mail: ums@edicto.de

UMS United Medical Systems International AGBorsteler Chaussee 53 D – 22453 Hamburg

UMS